img

Global Pediatric Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pediatric Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children’s formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.
Pediatric Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pediatric Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pediatric Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pediatric Drugs key manufacturers include Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech and GlaxoSmithKline, etc. Abbott Laboratories, Bayer, Boehringer Ingelheim are top 3 players and held % sales share in total in 2022.
Pediatric Drugs can be divided into Allergy and Respiratory Drugs, Anti-Infectives, Cancer Therapies and Cardiovascular Drugs, etc. Allergy and Respiratory Drugs is the mainstream product in the market, accounting for % sales share globally in 2022.
Pediatric Drugs is widely used in various fields, such as Hospital, Clinic and Drugstore,, etc. Hospital provides greatest supports to the Pediatric Drugs industry development. In 2022, global % sales of Pediatric Drugs went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pediatric Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Colgate Oral Pharmaceuticals
Eli Lilly
Forest Laboratories
Genentech
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Novartis Pharmaceuticals
Novo Nordisk
Pfizer
Pharmacia
Roche
Schering-Plough
Segment by Type
Allergy and Respiratory Drugs
Anti-Infectives
Cancer Therapies
Cardiovascular Drugs
Central Nervous System Drugs
Gastrointestinal Drugs
Hormone Drugs
Urological Drugs

Segment by Application


Hospital
Clinic
Drugstore

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pediatric Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pediatric Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pediatric Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pediatric Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pediatric Drugs introduction, etc. Pediatric Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pediatric Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pediatric Drugs Market Overview
1.1 Pediatric Drugs Product Overview
1.2 Pediatric Drugs Market Segment by Type
1.2.1 Allergy and Respiratory Drugs
1.2.2 Anti-Infectives
1.2.3 Cancer Therapies
1.2.4 Cardiovascular Drugs
1.2.5 Central Nervous System Drugs
1.2.6 Gastrointestinal Drugs
1.2.7 Hormone Drugs
1.2.8 Urological Drugs
1.3 Global Pediatric Drugs Market Size by Type
1.3.1 Global Pediatric Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Pediatric Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pediatric Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pediatric Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pediatric Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Type (2018-2024)
2 Global Pediatric Drugs Market Competition by Company
2.1 Global Top Players by Pediatric Drugs Sales (2018-2024)
2.2 Global Top Players by Pediatric Drugs Revenue (2018-2024)
2.3 Global Top Players by Pediatric Drugs Price (2018-2024)
2.4 Global Top Manufacturers Pediatric Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Drugs Market Competitive Situation and Trends
2.5.1 Pediatric Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Pediatric Drugs Market
2.8 Key Manufacturers Pediatric Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Drugs Status and Outlook by Region
3.1 Global Pediatric Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pediatric Drugs Historic Market Size by Region
3.2.1 Global Pediatric Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Pediatric Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Pediatric Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pediatric Drugs Forecasted Market Size by Region
3.3.1 Global Pediatric Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Pediatric Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Pediatric Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pediatric Drugs by Application
4.1 Pediatric Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Drugstore
4.2 Global Pediatric Drugs Market Size by Application
4.2.1 Global Pediatric Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Pediatric Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pediatric Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pediatric Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pediatric Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pediatric Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pediatric Drugs Sales Breakdown by Application (2018-2024)
5 North America Pediatric Drugs by Country
5.1 North America Pediatric Drugs Historic Market Size by Country
5.1.1 North America Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pediatric Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Pediatric Drugs Sales in Value by Country (2018-2024)
5.2 North America Pediatric Drugs Forecasted Market Size by Country
5.2.1 North America Pediatric Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Pediatric Drugs Sales in Value by Country (2024-2034)
6 Europe Pediatric Drugs by Country
6.1 Europe Pediatric Drugs Historic Market Size by Country
6.1.1 Europe Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pediatric Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Pediatric Drugs Sales in Value by Country (2018-2024)
6.2 Europe Pediatric Drugs Forecasted Market Size by Country
6.2.1 Europe Pediatric Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Pediatric Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Pediatric Drugs by Region
7.1 Asia-Pacific Pediatric Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pediatric Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pediatric Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pediatric Drugs Sales in Value by Region (2024-2034)
8 Latin America Pediatric Drugs by Country
8.1 Latin America Pediatric Drugs Historic Market Size by Country
8.1.1 Latin America Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pediatric Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pediatric Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Pediatric Drugs Forecasted Market Size by Country
8.2.1 Latin America Pediatric Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pediatric Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Pediatric Drugs by Country
9.1 Middle East and Africa Pediatric Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pediatric Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pediatric Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pediatric Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Abbott Laboratories Pediatric Drugs Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Pediatric Drugs Products Offered
10.2.5 Bayer Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Pediatric Drugs Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Bristol-Myers Squibb Pediatric Drugs Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Colgate Oral Pharmaceuticals
10.5.1 Colgate Oral Pharmaceuticals Company Information
10.5.2 Colgate Oral Pharmaceuticals Introduction and Business Overview
10.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Products Offered
10.5.5 Colgate Oral Pharmaceuticals Recent Development
10.6 Eli Lilly
10.6.1 Eli Lilly Company Information
10.6.2 Eli Lilly Introduction and Business Overview
10.6.3 Eli Lilly Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Eli Lilly Pediatric Drugs Products Offered
10.6.5 Eli Lilly Recent Development
10.7 Forest Laboratories
10.7.1 Forest Laboratories Company Information
10.7.2 Forest Laboratories Introduction and Business Overview
10.7.3 Forest Laboratories Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Forest Laboratories Pediatric Drugs Products Offered
10.7.5 Forest Laboratories Recent Development
10.8 Genentech
10.8.1 Genentech Company Information
10.8.2 Genentech Introduction and Business Overview
10.8.3 Genentech Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Genentech Pediatric Drugs Products Offered
10.8.5 Genentech Recent Development
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information
10.9.2 GlaxoSmithKline Introduction and Business Overview
10.9.3 GlaxoSmithKline Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.9.4 GlaxoSmithKline Pediatric Drugs Products Offered
10.9.5 GlaxoSmithKline Recent Development
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information
10.10.2 Johnson & Johnson Introduction and Business Overview
10.10.3 Johnson & Johnson Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Johnson & Johnson Pediatric Drugs Products Offered
10.10.5 Johnson & Johnson Recent Development
10.11 MedImmune
10.11.1 MedImmune Company Information
10.11.2 MedImmune Introduction and Business Overview
10.11.3 MedImmune Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.11.4 MedImmune Pediatric Drugs Products Offered
10.11.5 MedImmune Recent Development
10.12 Merck
10.12.1 Merck Company Information
10.12.2 Merck Introduction and Business Overview
10.12.3 Merck Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Merck Pediatric Drugs Products Offered
10.12.5 Merck Recent Development
10.13 Novartis Pharmaceuticals
10.13.1 Novartis Pharmaceuticals Company Information
10.13.2 Novartis Pharmaceuticals Introduction and Business Overview
10.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Novartis Pharmaceuticals Pediatric Drugs Products Offered
10.13.5 Novartis Pharmaceuticals Recent Development
10.14 Novo Nordisk
10.14.1 Novo Nordisk Company Information
10.14.2 Novo Nordisk Introduction and Business Overview
10.14.3 Novo Nordisk Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Novo Nordisk Pediatric Drugs Products Offered
10.14.5 Novo Nordisk Recent Development
10.15 Pfizer
10.15.1 Pfizer Company Information
10.15.2 Pfizer Introduction and Business Overview
10.15.3 Pfizer Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Pfizer Pediatric Drugs Products Offered
10.15.5 Pfizer Recent Development
10.16 Pharmacia
10.16.1 Pharmacia Company Information
10.16.2 Pharmacia Introduction and Business Overview
10.16.3 Pharmacia Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Pharmacia Pediatric Drugs Products Offered
10.16.5 Pharmacia Recent Development
10.17 Roche
10.17.1 Roche Company Information
10.17.2 Roche Introduction and Business Overview
10.17.3 Roche Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Roche Pediatric Drugs Products Offered
10.17.5 Roche Recent Development
10.18 Schering-Plough
10.18.1 Schering-Plough Company Information
10.18.2 Schering-Plough Introduction and Business Overview
10.18.3 Schering-Plough Pediatric Drugs Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Schering-Plough Pediatric Drugs Products Offered
10.18.5 Schering-Plough Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Drugs Industrial Chain Analysis
11.4 Pediatric Drugs Market Dynamics
11.4.1 Pediatric Drugs Industry Trends
11.4.2 Pediatric Drugs Market Drivers
11.4.3 Pediatric Drugs Market Challenges
11.4.4 Pediatric Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Drugs Distributors
12.3 Pediatric Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Allergy and Respiratory Drugs
Table 2. Major Company of Anti-Infectives
Table 3. Major Company of Cancer Therapies
Table 4. Major Company of Cardiovascular Drugs
Table 5. Major Company of Central Nervous System Drugs
Table 6. Major Company of Gastrointestinal Drugs
Table 7. Major Company of Hormone Drugs
Table 8. Major Company of Urological Drugs
Table 9. Global Pediatric Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 10. Global Pediatric Drugs Sales by Type (2018-2024) & (K Units)
Table 11. Global Pediatric Drugs Sales Market Share in Volume by Type (2018-2024)
Table 12. Global Pediatric Drugs Sales by Type (2018-2024) & (US& Million)
Table 13. Global Pediatric Drugs Market Share in Value by Type (2018-2024)
Table 14. Global Pediatric Drugs Price by Type (2018-2024) & (USD/Unit)
Table 15. Global Pediatric Drugs Sales by Type (2024-2034) & (K Units)
Table 16. Global Pediatric Drugs Sales Market Share in Volume by Type (2024-2034)
Table 17. Global Pediatric Drugs Sales by Type (2024-2034) & (US$ Million)
Table 18. Global Pediatric Drugs Sales Market Share in Value by Type (2024-2034)
Table 19. Global Pediatric Drugs Price by Type (2024-2034) & (USD/Unit)
Table 20. North America Pediatric Drugs Sales by Type (2018-2024) & (K Units)
Table 21. North America Pediatric Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Europe Pediatric Drugs Sales (K Units) by Type (2018-2024)
Table 23. Europe Pediatric Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Asia-Pacific Pediatric Drugs Sales (K Units) by Type (2018-2024)
Table 25. Asia-Pacific Pediatric Drugs Sales by Type (2018-2024) & (US$ Million)
Table 26. Latin America Pediatric Drugs Sales (K Units) by Type (2018-2024)
Table 27. Latin America Pediatric Drugs Sales by Type (2018-2024) & (US$ Million)
Table 28. Middle East and Africa Pediatric Drugs Sales (K Units) by Type (2018-2024)
Table 29. Middle East and Africa Pediatric Drugs Sales by Type (2018-2024) & (US$ Million)
Table 30. Global Pediatric Drugs Sales by Company (2018-2024) & (K Units)
Table 31. Global Pediatric Drugs Sales Share by Company (2018-2024)
Table 32. Global Pediatric Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 33. Global Pediatric Drugs Revenue Share by Company (2018-2024)
Table 34. Global Market Pediatric Drugs Price by Company (2018-2024) & (USD/Unit)
Table 35. Global Pediatric Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Pediatric Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Drugs as of 2022)
Table 38. Date of Key Manufacturers Enter into Pediatric Drugs Market
Table 39. Key Manufacturers Pediatric Drugs Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Pediatric Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 42. Global Pediatric Drugs Sales by Region (2018-2024) & (K Units)
Table 43. Global Pediatric Drugs Sales Market Share in Volume by Region (2018-2024)
Table 44. Global Pediatric Drugs Sales by Region (2018-2024) & (US$ Million)
Table 45. Global Pediatric Drugs Sales Market Share in Value by Region (2018-2024)
Table 46. Global Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 47. Global Pediatric Drugs Sales by Region (2024-2034) & (K Units)
Table 48. Global Pediatric Drugs Sales Market Share in Volume by Region (2024-2034)
Table 49. Global Pediatric Drugs Sales by Region (2024-2034) & (US$ Million)
Table 50. Global Pediatric Drugs Sales Market Share in Value by Region (2024-2034)
Table 51. Global Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 52. Global Pediatric Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 53. Global Pediatric Drugs Sales by Application (2018-2024) & (K Units)
Table 54. Global Pediatric Drugs Sales Market Share in Volume by Application (2018-2024)
Table 55. Global Pediatric Drugs Sales by Application (2018-2024) & (US$ Million)
Table 56. Global Pediatric Drugs Sales Market Share in Value by Application (2018-2024)
Table 57. Global Pediatric Drugs Price by Application (2018-2024) & (USD/Unit)
Table 58. Global Pediatric Drugs Sales by Application (2024-2034) & (K Units)
Table 59. Global Pediatric Drugs Sales Market Share in Volume by Application (2024-2034)
Table 60. Global Pediatric Drugs Sales by Application (2024-2034) & (US$ Million)
Table 61. Global Pediatric Drugs Sales Market Share in Value by Application (2024-2034)
Table 62. Global Pediatric Drugs Price by Application (2024-2034) & (USD/Unit)
Table 63. North America Pediatric Drugs Sales by Application (2018-2024) (K Units)
Table 64. North America Pediatric Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Europe Pediatric Drugs Sales by Application (2018-2024) (K Units)
Table 66. Europe Pediatric Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. Asia-Pacific Pediatric Drugs Sales by Application (2018-2024) (K Units)
Table 68. Asia-Pacific Pediatric Drugs Sales by Application (2018-2024) & (US$ Million)
Table 69. Latin America Pediatric Drugs Sales by Application (2018-2024) (K Units)
Table 70. Latin America Pediatric Drugs Sales by Application (2018-2024) & (US$ Million)
Table 71. Middle East and Africa Pediatric Drugs Sales by Application (2018-2024) (K Units)
Table 72. Middle East and Africa Pediatric Drugs Sales by Application (2018-2024) & (US$ Million)
Table 73. North America Pediatric Drugs Sales by Country (2018-2024) & (K Units)
Table 74. North America Pediatric Drugs Sales Market Share in Volume by Country (2018-2024)
Table 75. North America Pediatric Drugs Sales by Country (2018-2024) & (US$ Million)
Table 76. North America Pediatric Drugs Sales Market Share in Value by Country (2018-2024)
Table 77. North America Pediatric Drugs Sales by Country (2024-2034) & (K Units)
Table 78. North America Pediatric Drugs Sales Market Share in Volume by Country (2024-2034)
Table 79. North America Pediatric Drugs Sales by Country (2024-2034) & (US$ Million)
Table 80. North America Pediatric Drugs Sales Market Share in Value by Country (2024-2034)
Table 81. Europe Pediatric Drugs Sales by Country (2018-2024) & (K Units)
Table 82. Europe Pediatric Drugs Sales Market Share in Volume by Country (2018-2024)
Table 83. Europe Pediatric Drugs Sales by Country (2018-2024) & (US$ Million)
Table 84. Europe Pediatric Drugs Sales Market Share in Value by Country (2018-2024)
Table 85. Europe Pediatric Drugs Sales by Country (2024-2034) & (K Units)
Table 86. Europe Pediatric Drugs Sales Market Share in Volume by Country (2024-2034)
Table 87. Europe Pediatric Drugs Sales by Country (2024-2034) & (US$ Million)
Table 88. Europe Pediatric Drugs Sales Market Share in Value by Country (2024-2034)
Table 89. Asia-Pacific Pediatric Drugs Sales by Region (2018-2024) & (K Units)
Table 90. Asia-Pacific Pediatric Drugs Sales Market Share in Volume by Region (2018-2024)
Table 91. Asia-Pacific Pediatric Drugs Sales by Region (2018-2024) & (US$ Million)
Table 92. Asia-Pacific Pediatric Drugs Sales Market Share in Value by Region (2018-2024)
Table 93. Asia-Pacific Pediatric Drugs Sales by Region (2024-2034) & (K Units)
Table 94. Asia-Pacific Pediatric Drugs Sales Market Share in Volume by Region (2024-2034)
Table 95. Asia-Pacific Pediatric Drugs Sales by Region (2024-2034) & (US$ Million)
Table 96. Asia-Pacific Pediatric Drugs Sales Market Share in Value by Region (2024-2034)
Table 97. Latin America Pediatric Drugs Sales by Country (2018-2024) & (K Units)
Table 98. Latin America Pediatric Drugs Sales Market Share in Volume by Country (2018-2024)
Table 99. Latin America Pediatric Drugs Sales by Country (2018-2024) & (US$ Million)
Table 100. Latin America Pediatric Drugs Sales Market Share in Value by Country (2018-2024)
Table 101. Latin America Pediatric Drugs Sales by Country (2024-2034) & (K Units)
Table 102. Latin America Pediatric Drugs Sales Market Share in Volume by Country (2024-2034)
Table 103. Latin America Pediatric Drugs Sales by Country (2024-2034) & (US$ Million)
Table 104. Latin America Pediatric Drugs Sales Market Share in Value by Country (2024-2034)
Table 105. Middle East and Africa Pediatric Drugs Sales by Country (2018-2024) & (K Units)
Table 106. Middle East and Africa Pediatric Drugs Sales Market Share in Volume by Country (2018-2024)
Table 107. Middle East and Africa Pediatric Drugs Sales by Country (2018-2024) & (US$ Million)
Table 108. Middle East and Africa Pediatric Drugs Sales Market Share in Value by Country (2018-2024)
Table 109. Middle East and Africa Pediatric Drugs Sales by Country (2024-2034) & (K Units)
Table 110. Middle East and Africa Pediatric Drugs Sales Market Share in Volume by Country (2024-2034)
Table 111. Middle East and Africa Pediatric Drugs Sales by Country (2024-2034) & (US$ Million)
Table 112. Middle East and Africa Pediatric Drugs Sales Market Share in Value by Country (2024-2034)
Table 113. Abbott Laboratories Company Information
Table 114. Abbott Laboratories Introduction and Business Overview
Table 115. Abbott Laboratories Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Abbott Laboratories Pediatric Drugs Product
Table 117. Abbott Laboratories Recent Development
Table 118. Bayer Company Information
Table 119. Bayer Introduction and Business Overview
Table 120. Bayer Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Bayer Pediatric Drugs Product
Table 122. Bayer Recent Development
Table 123. Boehringer Ingelheim Company Information
Table 124. Boehringer Ingelheim Introduction and Business Overview
Table 125. Boehringer Ingelheim Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Boehringer Ingelheim Pediatric Drugs Product
Table 127. Boehringer Ingelheim Recent Development
Table 128. Bristol-Myers Squibb Company Information
Table 129. Bristol-Myers Squibb Introduction and Business Overview
Table 130. Bristol-Myers Squibb Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Bristol-Myers Squibb Pediatric Drugs Product
Table 132. Bristol-Myers Squibb Recent Development
Table 133. Colgate Oral Pharmaceuticals Company Information
Table 134. Colgate Oral Pharmaceuticals Introduction and Business Overview
Table 135. Colgate Oral Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Colgate Oral Pharmaceuticals Pediatric Drugs Product
Table 137. Colgate Oral Pharmaceuticals Recent Development
Table 138. Eli Lilly Company Information
Table 139. Eli Lilly Introduction and Business Overview
Table 140. Eli Lilly Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. Eli Lilly Pediatric Drugs Product
Table 142. Eli Lilly Recent Development
Table 143. Forest Laboratories Company Information
Table 144. Forest Laboratories Introduction and Business Overview
Table 145. Forest Laboratories Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Forest Laboratories Pediatric Drugs Product
Table 147. Forest Laboratories Recent Development
Table 148. Genentech Company Information
Table 149. Genentech Introduction and Business Overview
Table 150. Genentech Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Genentech Pediatric Drugs Product
Table 152. Genentech Recent Development
Table 153. GlaxoSmithKline Company Information
Table 154. GlaxoSmithKline Introduction and Business Overview
Table 155. GlaxoSmithKline Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. GlaxoSmithKline Pediatric Drugs Product
Table 157. GlaxoSmithKline Recent Development
Table 158. Johnson & Johnson Company Information
Table 159. Johnson & Johnson Introduction and Business Overview
Table 160. Johnson & Johnson Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. Johnson & Johnson Pediatric Drugs Product
Table 162. Johnson & Johnson Recent Development
Table 163. MedImmune Company Information
Table 164. MedImmune Introduction and Business Overview
Table 165. MedImmune Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. MedImmune Pediatric Drugs Product
Table 167. MedImmune Recent Development
Table 168. Merck Company Information
Table 169. Merck Introduction and Business Overview
Table 170. Merck Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Merck Pediatric Drugs Product
Table 172. Merck Recent Development
Table 173. Novartis Pharmaceuticals Company Information
Table 174. Novartis Pharmaceuticals Introduction and Business Overview
Table 175. Novartis Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 176. Novartis Pharmaceuticals Pediatric Drugs Product
Table 177. Novartis Pharmaceuticals Recent Development
Table 178. Novo Nordisk Company Information
Table 179. Novo Nordisk Introduction and Business Overview
Table 180. Novo Nordisk Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 181. Novo Nordisk Pediatric Drugs Product
Table 182. Novo Nordisk Recent Development
Table 183. Pfizer Company Information
Table 184. Pfizer Introduction and Business Overview
Table 185. Pfizer Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 186. Pfizer Pediatric Drugs Product
Table 187. Pfizer Recent Development
Table 188. Pharmacia Company Information
Table 189. Pharmacia Introduction and Business Overview
Table 190. Pharmacia Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 191. Pharmacia Pediatric Drugs Product
Table 192. Pharmacia Recent Development
Table 193. Roche Company Information
Table 194. Roche Introduction and Business Overview
Table 195. Roche Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 196. Roche Pediatric Drugs Product
Table 197. Roche Recent Development
Table 198. Schering-Plough Company Information
Table 199. Schering-Plough Introduction and Business Overview
Table 200. Schering-Plough Pediatric Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 201. Schering-Plough Pediatric Drugs Product
Table 202. Schering-Plough Recent Development
Table 203. Key Raw Materials Lists
Table 204. Raw Materials Key Suppliers Lists
Table 205. Pediatric Drugs Market Trends
Table 206. Pediatric Drugs Market Drivers
Table 207. Pediatric Drugs Market Challenges
Table 208. Pediatric Drugs Market Restraints
Table 209. Pediatric Drugs Distributors List
Table 210. Pediatric Drugs Downstream Customers
Table 211. Research Programs/Design for This Report
Table 212. Key Data Information from Secondary Sources
Table 213. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Drugs Product Picture
Figure 2. Global Pediatric Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pediatric Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pediatric Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Allergy and Respiratory Drugs
Figure 6. Global Allergy and Respiratory Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Anti-Infectives
Figure 8. Global Anti-Infectives Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Cancer Therapies
Figure 10. Global Cancer Therapies Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Cardiovascular Drugs
Figure 12. Global Cardiovascular Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Central Nervous System Drugs
Figure 14. Global Central Nervous System Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Gastrointestinal Drugs
Figure 16. Global Gastrointestinal Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Product Picture of Hormone Drugs
Figure 18. Global Hormone Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 19. Product Picture of Urological Drugs
Figure 20. Global Urological Drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 21. Global Pediatric Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 22. Global Pediatric Drugs Sales Market Share by Type in 2022 & 2034
Figure 23. North America Pediatric Drugs Sales Market Share in Volume by Type in 2022
Figure 24. North America Pediatric Drugs Sales Market Share in Value by Type in 2022
Figure 25. Europe Pediatric Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Europe Pediatric Drugs Sales Market Share in Value by Type in 2022
Figure 27. Asia-Pacific Pediatric Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Asia-Pacific Pediatric Drugs Sales Market Share in Value by Type in 2022
Figure 29. Latin America Pediatric Drugs Sales Market Share in Volume by Type in 2022
Figure 30. Latin America Pediatric Drugs Sales Market Share in Value by Type in 2022
Figure 31. Middle East and Africa Pediatric Drugs Sales Market Share in Volume by Type in 2022
Figure 32. Middle East and Africa Pediatric Drugs Sales Market Share in Value by Type in 2022
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Drugs Sales in 2022
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Drugs Revenue in 2022
Figure 35. Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Product Picture of Hospital
Figure 37. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Clinic
Figure 39. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Product Picture of Drugstore
Figure 41. Global Drugstore Sales YoY Growth (2018-2034) & (K Units)
Figure 42. Global Pediatric Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 43. Global Pediatric Drugs Sales Market Share by Application in 2022 & 2034
Figure 44. North America Pediatric Drugs Sales Market Share in Volume by Application in 2022
Figure 45. North America Pediatric Drugs Sales Market Share in Value by Application in 2022
Figure 46. Europe Pediatric Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Europe Pediatric Drugs Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific Pediatric Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific Pediatric Drugs Sales Market Share in Value by Application in 2022
Figure 50. Latin America Pediatric Drugs Sales Market Share in Volume by Application in 2022
Figure 51. Latin America Pediatric Drugs Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa Pediatric Drugs Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. Pediatric Drugs Manufacturing Cost Structure
Figure 55. Pediatric Drugs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries